Raushan Kumar Chaudhary

Dr. Raushan Kumar Chaudhary

Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Mangalore, India
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
MPMelwin Johns Philip
Melwin Johns Philip
ASAshly Santhosh
Ashly Santhosh
SKSatish S. Karoli
Satish S. Karoli
RBRamesh Bhandari
Ramesh Bhandari
MGM.S. Ganachari
M.S. Ganachari

10 February 2022 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
SKSatish S. Karoli
Satish S. Karoli
PDPrarambh S R Dwivedi
Prarambh S R Dwivedi
RBRamesh Bhandari
Ramesh Bhandari

30 January 2023 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
PKPukar Khanal
Pukar Khanal
UMUday Venkat Mateti
Uday Venkat Mateti
CSC. S. Shastry
C. S. Shastry
JSJayarama Shetty
Jayarama Shetty
Cisplatin resistance is one of the major contributors to the poor survival rate among head and neck cancer (HNC) patients. Focusing on the protein–protein interaction rather than a single protein could provide a better understanding of drug resistance. Thus, this study aimed to identify hub genes in a complex network of cisplatin resistance associated genes in HNC chemotherapy via a series of bioinformatic tools. The genes involved in cisplatin resistance were retrieved from the NCBI gene database using “head and neck cancer” and “cisplatin resistance” as key words. The human genes retrieved were analyzed for their interactions and enriched using the STRING database. The interaction between KEGG pathways and genes was visualized in Cytoscape 3.7.2. Further, the hub gene was identified using the Cytohubba plugin of Cytoscape and validated using UALCAN and Human Protein Atlas database. Validated genes were investigated for the drug–gene interaction using the DGIbd database. Out of 137 genes obtained using key words, 133 were associated with cisplatin resistance in the human species. A total of 150 KEGG pathways, 82 cellular components, 123 molecular functions, and 1752 biological processes were modulated on enrichment analysis. Out of 37 hub genes, CCND1, AXL, CDKN2A, TERT, and EXH2 genes were found to have significant (p < 0.05) mRNA expression and effect on overall survival whereas protein expression was found to be positive for all the significant genes except TERT. Thus, they can be targeted with palbociclib, methotrexate, bortezomib and fluorouracil, sorafenib, dasatinib, carboplatin, paclitaxel, gemcitabine, imatinib, doxorubicin, and vorinostat. As the pathogenesis of head and neck cancer is complex, targeting hub genes and associated pathways involved in cisplatin resistance could bring a milestone change in the drug discovery and management of drug resistance which might uplift overall survival among HNC patients.

29 May 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
PRAKASH PATILPRAKASH PATIL
PRAKASH PATIL
LAL. Ananthesh
L. Ananthesh
MSMahendra Gowdru Srinivasa
Mahendra Gowdru Srinivasa
UMUday Venkat Mateti
Uday Venkat Mateti
PKPukar Khanal
Pukar Khanal

25 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
AAAkshay Ayappan
Akshay Ayappan
Bijaya Kumar PadhiBijaya Kumar Padhi
Bijaya Kumar Padhi
ALAnanthesh L.
Ananthesh L.
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
UMUday Venkat Mateti
Uday Venkat Mateti
Ranjit SahRanjit Sah
Ranjit Sah
Background: The current study aimed to identify the perceptions and issues regarding the affordability, availability, and accessibility of COVID-19 vaccination and determine the extent of vaccine hesitancy among non-vaccinated individuals. Methods: A Prospective cross-sectional study was conducted among 575 individuals for a period of six months. All the relevant information was collected using the peer-validated survey questionnaire. An independent t-test was applied to check the association between variables. Results: Among 575 participants, 80.8% were vaccinated, and 19.2% were non-vaccinated. Among the vaccinated, 35.1% were vaccinated in private centres and 64.9% in public health centres (PHC). In total, 32% had accessibility issues and 24.5% had availability issues. However, responders vaccinated at PHC were having more issues in comparison to other groups which was statistically significant (p < 0.05). Among the 163 privately vaccinated participants, 69.9% found it completely affordable. Another 26.9% and 3.1% found vaccines partly affordable and a little unaffordable. Among the 110 non-vaccinated, 38.1% were found to be vaccine-hesitant. Conclusions: Individuals vaccinated at PHC experienced issues such as long waiting times, unavailability of doses, and registration. Further, a significant level of hesitancy towards COVID-19 vaccines was observed. The safety and efficacy of COVID-19 vaccines contributed to negative attitudes.

21 July 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Raushan Kumar ChaudharyRaushan Kumar Chaudhary
Raushan Kumar Chaudhary
ALAnanthesh L.
Ananthesh L.
PRAKASH PATILPRAKASH PATIL
PRAKASH PATIL
UMUday Venkat Mateti
Uday Venkat Mateti
SSSanjit Sah
Sanjit Sah
Ranjit SahRanjit Sah
Ranjit Sah
Introduction: H5N1 is a highly pathogenic avian influenza virus that can infect humans and has an estimated fatality rate of 53%. As shown by the current situation of the COVID-19 pandemic, emerging and re-emerging viruses such as H5N1 have the potential to cause another pandemic. Thus, this study outlined the hub genes and pathways associated with H5N1 infection in humans. Methods: The genes associated with H5N1 infection in humans were retrieved from the NCBI Gene database using “H5N1 virus infection” as the keyword. The genes obtained were investigated for protein–protein interaction (PPI) using STRING version 11.5 and studied for functional enrichment analysis using DAVID 2021. Further, the PPI network was visualised and analysed using Cytoscape 3.7.2, and the hub genes were obtained using the local topological analysis method of the cytoHubba plugin. Results: A total of 39 genes associated with H5N1 infection in humans significantly interacted with each other, forming a PPI network with 38 nodes and 149 edges modulating 74 KEGG pathways, 76 biological processes, 13 cellular components, and 22 molecular functions. Further, the PPI network analysis revealed that 33 nodes interacted, forming 1056 shortest paths at 0.282 network density, along with a 1.947 characteristic path length. The local topological analysis predicted IFNA1, IRF3, CXCL8, CXCL10, IFNB1, and CHUK as the critical hub genes in human H5N1 infection. Conclusion: The hub genes associated with the H5N1 infection and their pathways could serve as diagnostic, prognostic, and therapeutic targets for H5N1 infection among humans.